Article Listing - Strong launch for Novartis’ Gilenya despite its time-consuming initiation process; study

EFPIA PRESIDENT DEFENDS PHARMA IND

20 April 1992

In the pharmaceutical sector, research and development spending is now so "repressive" that there is little chance of a reasonable...

ABPI WARNING ON COUNTERFEIT DRUGS

20 April 1992

The Association of the British Phar-maceutical Industry has called for more stringent controls on imported pharmaceuticals, although admitting that National...

STRONG INCREASES IN 1991 AT BRISTOL-MYERS SQUIBB

20 April 1992

New sales and earnings records were achieved by the US pharmaceutical concern Bristol-Myers Squibb in 1991, according to its annual...

MARKER TEST FOR BREAST CANCER

20 April 1992

A new marker diagnostic test that may lead to a cut in the number of cases of breast cancer by...

ISRAEL SICK FUND MEMBERS SURVEYED

20 April 1992

Yediot Aharonot, Israel's leading daily newspaper, has published results of a survey by the Brendman Institute into Israeli public attitudes...

MONGOLIAN DRUG PRICES FIXED

20 April 1992

The government of Mongolia has fixed the prices of medicines in the country for the rest of the year, reports...

BOEH MANNHEIM/RATIO LEGAL BATTLE

20 April 1992

The role of the German drug law in possibly creating conditions where drugs can be modified and marketed without regulatory...

IMPROVEMENTS IN 1ST QTR FOR US FIRMS

20 April 1992

Confirming signs of growth in the first quarter, as already indicated by Abbott Laboratories (Market-letter April 13), American Home Products...

NEW PRESIDENT FOR STERLING HEALTH CANADA

20 April 1992

Robert Steinman has been named as president of non-prescription drug company Sterling Health Canada.

APPOINTMENTS IN WYETH-AYERST GROUP

20 April 1992

Etienne Attar has been promoted to vice president, sales and marketing at Ayerst Laborat-ories in Canada. He succeeds Jeff Boily,...

Showing 94181-94190 of 95333 articles